A Phase la/lb, Open-Label, Multiple-Dose, Dose-Escalation and Expansion Study of the Anti-PD-1 Monoclonal Antibody CS1003 in Subjects with Advanced Solid Tumors

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/MonH/3
NMA SSA Reference Number: SSA/18/MonH/362
Monash Health Ref: RES-18-0000-038A
Effective start/end date6/06/195/06/24


  • clinical trial
  • treatment efficacy
  • solid tumours